PrognoScan also showed that XIST played an unfavourable prognostic role in several cancers, including BLCA (Figure 4A, OS: Cox P = 0.0192), non-small-cell lung cancer (NSCLC, Figure 4L, RFS: Cox P = 0.0084) and renal cell carcinoma (RCC, Figure 4N, OS: Cox P = 0.0327). Here, XIST is linked to hereditary clear cell renal cell carcinoma.